Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Response to Letter: Corticosteroids for Oesophageal Caustic Injuries.

Akobeng AK, Abdelgadir I.

J Pediatr Gastroenterol Nutr. 2019 Sep 20. doi: 10.1097/MPG.0000000000002509. [Epub ahead of print] No abstract available.

PMID:
31567885
2.

Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.

Iheozor-Ejiofor Z, Gordon M, Clegg A, Freeman SC, Gjuladin-Hellon T, MacDonald JK, Akobeng AK.

Cochrane Database Syst Rev. 2019 Sep 12;9:CD013210. doi: 10.1002/14651858.CD013210.pub2.

PMID:
31513295
3.

Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.

Gjuladin-Hellon T, Iheozor-Ejiofor Z, Gordon M, Akobeng AK.

Cochrane Database Syst Rev. 2019 Aug 6;8:CD010233. doi: 10.1002/14651858.CD010233.pub3.

PMID:
31425621
4.

Stillbirth and associated perinatal outcomes in obstetric cholestasis: a systematic review and meta-analysis of observational studies.

Mohan M, Antonios A, Konje J, Lindow S, Ahmed Syed M, Akobeng A.

Eur J Obstet Gynecol Reprod Biol X. 2019 May 2;3:100026. doi: 10.1016/j.eurox.2019.100026. eCollection 2019 Jul. Review.

5.

Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

Gjuladin-Hellon T, Gordon M, Iheozor-Ejiofor Z, Akobeng AK.

Cochrane Database Syst Rev. 2019 Jun 20;6:CD008414. doi: 10.1002/14651858.CD008414.pub3.

PMID:
31220875
6.

Probiotics to prevent infantile colic.

Ong TG, Gordon M, Banks SS, Thomas MR, Akobeng AK.

Cochrane Database Syst Rev. 2019 Mar 13;3:CD012473. doi: 10.1002/14651858.CD012473.pub2.

PMID:
30865287
7.

Enteral nutrition for maintenance of remission in Crohn's disease.

Akobeng AK, Zhang D, Gordon M, MacDonald JK.

Cochrane Database Syst Rev. 2018 Aug 11;8:CD005984. doi: 10.1002/14651858.CD005984.pub3.

8.

Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis.

Abdelgadir IS, Gordon MA, Akobeng AK.

Arch Dis Child. 2018 Dec;103(12):1155-1162. doi: 10.1136/archdischild-2017-314181. Epub 2018 May 2.

PMID:
29720494
9.

Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.

Akobeng AK.

Acta Paediatr. 2018 Nov;107(11):2019-2023. doi: 10.1111/apa.14374. Epub 2018 May 21.

PMID:
29706011
10.

Patent foramen ovale (PFO) closure versus medical therapy for prevention of recurrent stroke in patients with prior cryptogenic stroke: A systematic review and meta-analysis of randomized controlled trials.

Akobeng AK, Abdelgadir I, Boudjemline Y, Hijazi ZM.

Catheter Cardiovasc Interv. 2018 Jul;92(1):165-173. doi: 10.1002/ccd.27615. Epub 2018 Mar 30.

PMID:
29602258
11.

Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response.

Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK.

J Pediatr Gastroenterol Nutr. 2018 Feb;66(2):274-280. doi: 10.1097/MPG.0000000000001679.

PMID:
29356768
12.

Corticosteroids for Preventing Caustic Esophageal Strictures: Systematic Review and Meta-analysis.

Katibe R, Abdelgadir I, McGrogan P, Akobeng AK.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):898-902. doi: 10.1097/MPG.0000000000001852.

PMID:
29216023
13.

Real-Life Anti-Tumour Necrosis Factor Experience in > 500 Paediatric United Kingdom Inflammatory Bowel Disease Patients.

Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MK, Elawad M, Fell JM, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK.

J Pediatr Gastroenterol Nutr. 2017 Jul 27. doi: 10.1097/MPG.0000000000001679. [Epub ahead of print]

PMID:
28753181
14.

Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.

Akobeng AK, Zhang D, Gordon M, MacDonald JK.

Cochrane Database Syst Rev. 2016 Sep 28;9:CD003715. doi: 10.1002/14651858.CD003715.pub3. Review.

15.

Osmotic and stimulant laxatives for the management of childhood constipation.

Gordon M, MacDonald JK, Parker CE, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2016 Aug 17;(8):CD009118. doi: 10.1002/14651858.CD009118.pub3. Review.

16.

Understanding type I and type II errors, statistical power and sample size.

Akobeng AK.

Acta Paediatr. 2016 Jun;105(6):605-9. doi: 10.1111/apa.13384. Epub 2016 Mar 31. Review.

PMID:
26935977
17.

Glutamine for induction of remission in Crohn's disease.

Akobeng AK, Elawad M, Gordon M.

Cochrane Database Syst Rev. 2016 Feb 8;2:CD007348. doi: 10.1002/14651858.CD007348.pub2. Review.

PMID:
26853855
18.

Racecadotril for acute diarrhoea in children: systematic review and meta-analyses.

Gordon M, Akobeng A.

Arch Dis Child. 2016 Mar;101(3):234-40. doi: 10.1136/archdischild-2015-309676. Epub 2015 Dec 29. Review.

19.

Telephone Consultation as a Substitute for Routine Out-patient Face-to-face Consultation for Children With Inflammatory Bowel Disease: Randomised Controlled Trial and Economic Evaluation.

Akobeng AK, O'Leary N, Vail A, Brown N, Widiatmoko D, Fagbemi A, Thomas AG.

EBioMedicine. 2015 Aug 8;2(9):1251-6. doi: 10.1016/j.ebiom.2015.08.011. eCollection 2015 Sep.

20.

Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us?

Akobeng AA, Sandborn WJ, Bickston SJ, Chande N, Shackelton LM, Nelson S, Feagan BG.

Inflamm Bowel Dis. 2014 Nov;20(11):2132-41. doi: 10.1097/MIB.0000000000000218. Review.

PMID:
25299543
21.

Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Taylor K, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2014 Aug 1;(8):CD010233. doi: 10.1002/14651858.CD010233.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Aug 06;8:CD010233.

22.

Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Review.

PMID:
23878124
23.

Osmotic and stimulant laxatives for the management of childhood constipation.

Gordon M, Naidoo K, Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009118. doi: 10.1002/14651858.CD009118.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD009118.

PMID:
22786523
24.

The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD).

Malik S, Ahmed SF, Wilson ML, Shah N, Loganathan S, Naik S, Bourke B, Thomas A, Akobeng AK, Fagbemi A, Wilson DC, Russell RK.

J Crohns Colitis. 2012 Apr;6(3):337-44. doi: 10.1016/j.crohns.2011.09.004. Epub 2011 Oct 15.

PMID:
22405171
25.

Probiotics for maintenance of remission in ulcerative colitis.

Naidoo K, Gordon M, Fagbemi AO, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007443. doi: 10.1002/14651858.CD007443.pub2. Review.

PMID:
22161412
26.

Efficacy of 5-aminosalicylates for the maintenance of remission in Crohn's disease.

Akobeng AK.

Am J Gastroenterol. 2011 Oct;106(10):1857; author reply 1857-8. doi: 10.1038/ajg.2011.217. No abstract available.

PMID:
21979212
27.

Validation of an instrument to measure quality of life in British children with inflammatory bowel disease.

Ogden CA, Akobeng AK, Abbott J, Aggett P, Sood MR, Thomas AG.

J Pediatr Gastroenterol Nutr. 2011 Sep;53(3):280-6. doi: 10.1097/MPG.0b013e3182165d10.

PMID:
21865975
28.

A British Society of Paediatric Gastroenterology, Hepatology and Nutrition survey of the effectiveness and safety of adalimumab in children with inflammatory bowel disease.

Russell RK, Wilson ML, Loganathan S, Bourke B, Kiparissi F, Mahdi G, Torrente F, Rodrigues A, Davies I, Thomas A, Akobeng AK, Fagbemi A, Hyer W, Spray C, Vaish S, Rogers P, McGrogan P, Heuschkel RB, Ayub N, Fell JM, Afzal NA, Green M, Murphy MS, Rao P, Shah N, Ho GT, Naik S, Wilson DC.

Aliment Pharmacol Ther. 2011 Apr;33(8):946-53. doi: 10.1111/j.1365-2036.2011.04603.x. Epub 2011 Feb 22.

29.

Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease.

Gordon M, Naidoo K, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008414. doi: 10.1002/14651858.CD008414.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Jun 20;6:CD008414.

PMID:
21249709
30.

Severe hypokalemia due to an inappropriate formula milk.

Osuagwu MN, Gordon M, Akobeng AK.

Clin Pediatr (Phila). 2012 Jan;51(1):86-7. doi: 10.1177/0009922810389171. Epub 2010 Dec 6. No abstract available.

PMID:
21138850
31.

Refeeding syndrome following exclusive enteral nutritional treatment in Crohn disease.

Akobeng AK, Thomas AG.

J Pediatr Gastroenterol Nutr. 2010 Sep;51(3):364-6. doi: 10.1097/MPG.0b013e3181e712d6. No abstract available.

PMID:
20639770
32.

Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease.

Wilson DC, Thomas AG, Croft NM, Newby E, Akobeng AK, Sawczenko A, Fell JM, Murphy MS, Beattie RM, Sandhu BK, Mitton SG; IBD Working Group of the British Society of Paediatric Gastroenterology, Hepatology, and Nutrition, Casson D, Elawad M, Heuschkel R, Jenkins H, Johnson T, Macdonald S, Murch SH.

J Pediatr Gastroenterol Nutr. 2010 Feb;50 Suppl 1:S14-34. doi: 10.1097/MPG.0b013e3181c92caa. Review.

PMID:
20081542
33.

Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease.

Akobeng AK, Stokkers PC.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007351. doi: 10.1002/14651858.CD007351.pub2. Review.

PMID:
19370685
34.

Thalidomide and thalidomide analogues for induction of remission in Crohn's disease.

Srinivasan R, Akobeng AK.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007350. doi: 10.1002/14651858.CD007350.pub2. Review.

PMID:
19370684
35.

Diagnosis and management of the first reported case of esophageal, gastric, and small-bowel heterotopia in the colon, using confocal laser endomicroscopy.

Venkatesh K, Cohen M, Akobeng A, Ashok D, Abou-Taleb A, Evans C, Howarth K, Taylor C, Thomson M.

Endoscopy. 2009;41 Suppl 2:E58. doi: 10.1055/s-2008-1077771. Epub 2009 Mar 24. No abstract available.

PMID:
19319780
36.

Assessing the validity of clinical trials.

Akobeng AK.

J Pediatr Gastroenterol Nutr. 2008 Sep;47(3):277-82. doi: 10.1097/MPG.0b013e31816c749f. Review.

PMID:
18728521
37.

Probiotics for induction of remission in Crohn's disease.

Butterworth AD, Thomas AG, Akobeng AK.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006634. doi: 10.1002/14651858.CD006634.pub2. Review.

38.

Anti-mycobacterials and Crohn's disease: author's reply.

Akobeng AK.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):374-5. No abstract available.

39.

Confidence intervals and p-values in clinical decision making.

Akobeng AK.

Acta Paediatr. 2008 Aug;97(8):1004-7. doi: 10.1111/j.1651-2227.2008.00836.x. Epub 2008 May 7.

PMID:
18462462
40.

Crohn's disease: current treatment options.

Akobeng AK.

Arch Dis Child. 2008 Sep;93(9):787-92. doi: 10.1136/adc.2007.128751. Epub 2008 May 2. Review.

PMID:
18456695
41.

Communicating the benefits and harms of treatments.

Akobeng AK.

Arch Dis Child. 2008 Aug;93(8):710-3. doi: 10.1136/adc.2008.137083. Epub 2008 May 2. Review.

PMID:
18456681
42.

Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis.

Zipitis CS, Akobeng AK.

Arch Dis Child. 2008 Jun;93(6):512-7. doi: 10.1136/adc.2007.128579. Epub 2008 Mar 13. Review.

PMID:
18339654
43.

Systematic review: tolerable amount of gluten for people with coeliac disease.

Akobeng AK, Thomas AG.

Aliment Pharmacol Ther. 2008 Jun 1;27(11):1044-52. doi: 10.1111/j.1365-2036.2008.03669.x. Epub 2008 Feb 29. Review.

44.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Colombel JF, Sandborn WJ, Rutgeerts P et al. Gastroenterology 2007;132:52-65.

Jilani NZ, Akobeng AK.

J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):226-7. doi: 10.1097/MPG.0b013e318156e139. No abstract available.

PMID:
18223389
45.

Review article: the evidence base for interventions used to maintain remission in Crohn's disease.

Akobeng AK.

Aliment Pharmacol Ther. 2008 Jan 1;27(1):11-8. Epub 2007 Oct 5. Review.

46.

Enteral nutrition for maintenance of remission in Crohn's disease.

Akobeng AK, Thomas AG.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005984. Review. Update in: Cochrane Database Syst Rev. 2018 Aug 11;8:CD005984.

PMID:
17636816
47.
48.

Understanding diagnostic tests 3: Receiver operating characteristic curves.

Akobeng AK.

Acta Paediatr. 2007 May;96(5):644-7. Epub 2007 Mar 21. Review.

PMID:
17376185
49.
50.

Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn's disease.

Akobeng AK, Richmond K, Miller V, Thomas AG.

Clin Nutr. 2007 Feb;26(1):51-6. Epub 2006 Dec 11.

PMID:
17161887

Supplemental Content

Loading ...
Support Center